Jill Milne is the founder of Catabasis Pharmaceuticals. Catabasis Pharmaceuticals has raised $72M in total funding. Latest round: Series B.
Jill C. Milne, Ph.D., is a serial biotech entrepreneur. She served as President and Chief Executive Officer of Catabasis Pharmaceuticals, a Cambridge, Massachusetts-based clinical-stage company. She is currently CEO of Astria Therapeutics, the company formerly known as Catabasis Pharmaceuticals after its 2021 rebranding.
Full founder directory · Investor directory · Company funding database · Fundraising library